nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—Lymphopenia—Riluzole—amyotrophic lateral sclerosis	0.0236	0.0879	CcSEcCtD
Carfilzomib—Hypercalcaemia—Riluzole—amyotrophic lateral sclerosis	0.0174	0.0648	CcSEcCtD
Carfilzomib—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.0162	0.0603	CcSEcCtD
Carfilzomib—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.015	0.056	CcSEcCtD
Carfilzomib—PSMB1—embryo—amyotrophic lateral sclerosis	0.0132	0.0677	CbGeAlD
Carfilzomib—PSMB2—embryo—amyotrophic lateral sclerosis	0.0129	0.0661	CbGeAlD
Carfilzomib—PSMB10—nervous system—amyotrophic lateral sclerosis	0.0127	0.0653	CbGeAlD
Carfilzomib—PSMB10—central nervous system—amyotrophic lateral sclerosis	0.0122	0.0629	CbGeAlD
Carfilzomib—PSMB10—cerebellum—amyotrophic lateral sclerosis	0.012	0.0615	CbGeAlD
Carfilzomib—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.0105	0.039	CcSEcCtD
Carfilzomib—PSMB10—brain—amyotrophic lateral sclerosis	0.00972	0.0499	CbGeAlD
Carfilzomib—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00966	0.036	CcSEcCtD
Carfilzomib—PSMB5—medulla oblongata—amyotrophic lateral sclerosis	0.00963	0.0495	CbGeAlD
Carfilzomib—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00879	0.0328	CcSEcCtD
Carfilzomib—PSMB5—spinal cord—amyotrophic lateral sclerosis	0.00859	0.0441	CbGeAlD
Carfilzomib—PSMB1—medulla oblongata—amyotrophic lateral sclerosis	0.00842	0.0433	CbGeAlD
Carfilzomib—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00833	0.0311	CcSEcCtD
Carfilzomib—PSMB2—medulla oblongata—amyotrophic lateral sclerosis	0.00821	0.0422	CbGeAlD
Carfilzomib—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00797	0.0297	CcSEcCtD
Carfilzomib—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00789	0.0294	CcSEcCtD
Carfilzomib—PSMB1—spinal cord—amyotrophic lateral sclerosis	0.00751	0.0386	CbGeAlD
Carfilzomib—PSMB2—spinal cord—amyotrophic lateral sclerosis	0.00732	0.0376	CbGeAlD
Carfilzomib—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00708	0.0264	CcSEcCtD
Carfilzomib—PSMB5—cerebellum—amyotrophic lateral sclerosis	0.00681	0.035	CbGeAlD
Carfilzomib—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00679	0.0253	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00665	0.0248	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00662	0.0247	CcSEcCtD
Carfilzomib—PSMB1—nervous system—amyotrophic lateral sclerosis	0.00633	0.0325	CbGeAlD
Carfilzomib—PSMB8—brain—amyotrophic lateral sclerosis	0.00626	0.0322	CbGeAlD
Carfilzomib—PSMB2—nervous system—amyotrophic lateral sclerosis	0.00617	0.0317	CbGeAlD
Carfilzomib—PSMB1—central nervous system—amyotrophic lateral sclerosis	0.00609	0.0313	CbGeAlD
Carfilzomib—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00603	0.0225	CcSEcCtD
Carfilzomib—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00597	0.0223	CcSEcCtD
Carfilzomib—PSMB1—cerebellum—amyotrophic lateral sclerosis	0.00595	0.0306	CbGeAlD
Carfilzomib—PSMB2—central nervous system—amyotrophic lateral sclerosis	0.00594	0.0305	CbGeAlD
Carfilzomib—PSMB2—cerebellum—amyotrophic lateral sclerosis	0.00581	0.0298	CbGeAlD
Carfilzomib—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00562	0.021	CcSEcCtD
Carfilzomib—PSMB5—brain—amyotrophic lateral sclerosis	0.00553	0.0284	CbGeAlD
Carfilzomib—Chills—Riluzole—amyotrophic lateral sclerosis	0.00544	0.0203	CcSEcCtD
Carfilzomib—Back pain—Riluzole—amyotrophic lateral sclerosis	0.0051	0.019	CcSEcCtD
Carfilzomib—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00507	0.0189	CcSEcCtD
Carfilzomib—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00487	0.0182	CcSEcCtD
Carfilzomib—PSMB1—brain—amyotrophic lateral sclerosis	0.00484	0.0248	CbGeAlD
Carfilzomib—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00472	0.0176	CcSEcCtD
Carfilzomib—PSMB2—brain—amyotrophic lateral sclerosis	0.00472	0.0242	CbGeAlD
Carfilzomib—Cough—Riluzole—amyotrophic lateral sclerosis	0.0046	0.0172	CcSEcCtD
Carfilzomib—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00455	0.017	CcSEcCtD
Carfilzomib—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00449	0.0167	CcSEcCtD
Carfilzomib—Infection—Riluzole—amyotrophic lateral sclerosis	0.00428	0.0159	CcSEcCtD
Carfilzomib—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00421	0.0157	CcSEcCtD
Carfilzomib—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.0041	0.0153	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00392	0.0146	CcSEcCtD
Carfilzomib—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00389	0.0145	CcSEcCtD
Carfilzomib—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00384	0.0143	CcSEcCtD
Carfilzomib—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00374	0.014	CcSEcCtD
Carfilzomib—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00371	0.0138	CcSEcCtD
Carfilzomib—Pain—Riluzole—amyotrophic lateral sclerosis	0.00368	0.0137	CcSEcCtD
Carfilzomib—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00368	0.0137	CcSEcCtD
Carfilzomib—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.0034	0.0127	CcSEcCtD
Carfilzomib—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00309	0.0115	CcSEcCtD
Carfilzomib—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00295	0.011	CcSEcCtD
Carfilzomib—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00285	0.0106	CcSEcCtD
Carfilzomib—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00274	0.0102	CcSEcCtD
Carfilzomib—Headache—Riluzole—amyotrophic lateral sclerosis	0.0027	0.0101	CcSEcCtD
Carfilzomib—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00953	CcSEcCtD
Carfilzomib—ABCB1—embryo—amyotrophic lateral sclerosis	0.00196	0.0101	CbGeAlD
Carfilzomib—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.00125	0.00645	CbGeAlD
Carfilzomib—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.00112	0.00575	CbGeAlD
Carfilzomib—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000943	0.00485	CbGeAlD
Carfilzomib—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000908	0.00466	CbGeAlD
Carfilzomib—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000887	0.00456	CbGeAlD
Carfilzomib—ABCB1—brain—amyotrophic lateral sclerosis	0.000721	0.0037	CbGeAlD
Carfilzomib—PSMB9—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000361	0.000671	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—C3—amyotrophic lateral sclerosis	0.000354	0.000659	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—C3—amyotrophic lateral sclerosis	0.000353	0.000656	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000351	0.000654	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000351	0.000654	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—GSR—amyotrophic lateral sclerosis	0.000351	0.000654	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—GSR—amyotrophic lateral sclerosis	0.000346	0.000645	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000338	0.00063	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000337	0.000626	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000331	0.000615	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	0.000323	0.000601	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	0.000323	0.000601	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	0.000323	0.000601	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000322	0.000599	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00032	0.000596	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	0.000318	0.000593	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000318	0.000592	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000318	0.000592	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000318	0.000592	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000318	0.000592	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—ATF1—amyotrophic lateral sclerosis	0.000317	0.00059	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000317	0.00059	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—ATF1—amyotrophic lateral sclerosis	0.000316	0.000588	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000314	0.000584	CbGpPWpGaD
Carfilzomib—PSMB1—Apoptosis—TP53—amyotrophic lateral sclerosis	0.000304	0.000565	CbGpPWpGaD
Carfilzomib—PSMB5—Apoptosis—TP53—amyotrophic lateral sclerosis	0.000304	0.000565	CbGpPWpGaD
Carfilzomib—PSMB2—Apoptosis—TP53—amyotrophic lateral sclerosis	0.000304	0.000565	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	0.000304	0.000565	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	0.000304	0.000565	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	0.000304	0.000565	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CASP9—amyotrophic lateral sclerosis	0.000302	0.000562	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CASP9—amyotrophic lateral sclerosis	0.000301	0.00056	CbGpPWpGaD
Carfilzomib—PSMB8—Apoptosis—TP53—amyotrophic lateral sclerosis	0.000299	0.000557	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	0.000299	0.000557	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000299	0.000557	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000299	0.000557	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000299	0.000557	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000295	0.000549	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CST3—amyotrophic lateral sclerosis	0.000291	0.000541	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CST3—amyotrophic lateral sclerosis	0.000291	0.000541	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CST3—amyotrophic lateral sclerosis	0.000291	0.000541	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000288	0.000537	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000288	0.000537	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000288	0.000537	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CST3—amyotrophic lateral sclerosis	0.000287	0.000533	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000284	0.000529	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000284	0.000528	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000284	0.000528	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000284	0.000528	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00028	0.000521	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.00028	0.000521	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—CASP9—amyotrophic lateral sclerosis	0.000279	0.000519	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—CASP9—amyotrophic lateral sclerosis	0.000278	0.000517	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000275	0.000511	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000275	0.000511	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000275	0.000511	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000271	0.000504	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—C3—amyotrophic lateral sclerosis	0.000268	0.0005	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—C3—amyotrophic lateral sclerosis	0.000268	0.0005	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—C3—amyotrophic lateral sclerosis	0.000268	0.0005	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—C3—amyotrophic lateral sclerosis	0.000265	0.000493	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000259	0.000481	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000257	0.000479	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000256	0.000477	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000256	0.000477	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000256	0.000477	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000253	0.00047	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000244	0.000454	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000244	0.000454	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000244	0.000454	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000243	0.000453	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000242	0.00045	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000241	0.000449	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000241	0.000449	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000241	0.000449	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00024	0.000448	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—ATF1—amyotrophic lateral sclerosis	0.00024	0.000447	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—ATF1—amyotrophic lateral sclerosis	0.00024	0.000447	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—ATF1—amyotrophic lateral sclerosis	0.00024	0.000447	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	0.000239	0.000445	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—ERBB4—amyotrophic lateral sclerosis	0.000239	0.000444	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000238	0.000443	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—ERBB4—amyotrophic lateral sclerosis	0.000238	0.000442	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—ATF1—amyotrophic lateral sclerosis	0.000237	0.000441	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000236	0.000439	CbGpPWpGaD
Carfilzomib—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000234	0.000436	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CASP9—amyotrophic lateral sclerosis	0.000229	0.000426	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CASP9—amyotrophic lateral sclerosis	0.000229	0.000426	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CASP9—amyotrophic lateral sclerosis	0.000229	0.000426	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CASP9—amyotrophic lateral sclerosis	0.000226	0.00042	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000225	0.000419	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000219	0.000407	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000218	0.000405	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—C3—amyotrophic lateral sclerosis	0.000215	0.0004	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—C3—amyotrophic lateral sclerosis	0.000214	0.000398	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000213	0.000397	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CASP9—amyotrophic lateral sclerosis	0.000211	0.000393	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CASP9—amyotrophic lateral sclerosis	0.000211	0.000393	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CASP9—amyotrophic lateral sclerosis	0.000211	0.000393	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CASP9—amyotrophic lateral sclerosis	0.000208	0.000388	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000205	0.000382	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000205	0.000381	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000204	0.00038	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000204	0.00038	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000204	0.00038	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000204	0.000379	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	0.000203	0.000377	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000196	0.000365	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000196	0.000365	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000196	0.000365	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000195	0.000364	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000194	0.000362	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000193	0.00036	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000188	0.00035	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000187	0.000348	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000187	0.000348	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—APOE—amyotrophic lateral sclerosis	0.000185	0.000344	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000184	0.000343	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000184	0.000343	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000184	0.000343	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—APOE—amyotrophic lateral sclerosis	0.000184	0.000342	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000182	0.000338	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000181	0.000337	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000181	0.000337	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—ERBB4—amyotrophic lateral sclerosis	0.000181	0.000337	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—ERBB4—amyotrophic lateral sclerosis	0.000181	0.000337	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—ERBB4—amyotrophic lateral sclerosis	0.000181	0.000337	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—ERBB4—amyotrophic lateral sclerosis	0.000178	0.000332	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000174	0.000323	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000167	0.000311	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000166	0.00031	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000166	0.000308	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000166	0.000308	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000166	0.000308	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000163	0.000304	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000163	0.000304	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—C3—amyotrophic lateral sclerosis	0.000163	0.000303	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—C3—amyotrophic lateral sclerosis	0.000163	0.000303	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—C3—amyotrophic lateral sclerosis	0.000163	0.000303	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000161	0.000301	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—C3—amyotrophic lateral sclerosis	0.000161	0.000299	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000157	0.000293	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000156	0.000291	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000155	0.000289	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000155	0.000289	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000155	0.000289	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000155	0.000289	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000155	0.000289	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000155	0.000289	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—APOE—amyotrophic lateral sclerosis	0.000155	0.000288	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—APOE—amyotrophic lateral sclerosis	0.000154	0.000287	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000153	0.000285	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000153	0.000285	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000153	0.000284	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000148	0.000276	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000148	0.000276	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000148	0.000276	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000148	0.000275	CbGpPWpGaD
Carfilzomib—PSMB10—Cell Cycle—TP53—amyotrophic lateral sclerosis	0.000147	0.000273	CbGpPWpGaD
Carfilzomib—PSMB9—Cell Cycle—TP53—amyotrophic lateral sclerosis	0.000146	0.000272	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000146	0.000272	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000142	0.000265	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000142	0.000265	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000142	0.000265	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00014	0.000261	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—APOE—amyotrophic lateral sclerosis	0.00014	0.000261	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—APOE—amyotrophic lateral sclerosis	0.00014	0.000261	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—APOE—amyotrophic lateral sclerosis	0.00014	0.000261	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000139	0.000259	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000138	0.000257	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—APOE—amyotrophic lateral sclerosis	0.000138	0.000257	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000129	0.000241	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000129	0.00024	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000127	0.000236	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000127	0.000236	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000127	0.000236	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000127	0.000236	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—PTGS2—amyotrophic lateral sclerosis	0.000127	0.000236	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—PTGS2—amyotrophic lateral sclerosis	0.000126	0.000234	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000125	0.000232	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000119	0.000222	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000119	0.000222	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000119	0.000222	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000118	0.00022	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000117	0.000219	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000117	0.000218	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—APOE—amyotrophic lateral sclerosis	0.000117	0.000218	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000117	0.000218	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—APOE—amyotrophic lateral sclerosis	0.000116	0.000215	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000112	0.000208	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle—TP53—amyotrophic lateral sclerosis	0.000111	0.000207	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle—TP53—amyotrophic lateral sclerosis	0.000111	0.000207	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle—TP53—amyotrophic lateral sclerosis	0.000111	0.000207	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle—TP53—amyotrophic lateral sclerosis	0.00011	0.000204	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000107	0.000199	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000106	0.000198	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000106	0.000197	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000105	0.000196	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000105	0.000196	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000105	0.000196	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000105	0.000196	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000104	0.000193	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000103	0.000192	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.0001	0.000186	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.8e-05	0.000182	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.8e-05	0.000182	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.8e-05	0.000182	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.66e-05	0.00018	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—PTGS2—amyotrophic lateral sclerosis	9.59e-05	0.000179	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—PTGS2—amyotrophic lateral sclerosis	9.59e-05	0.000179	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—PTGS2—amyotrophic lateral sclerosis	9.59e-05	0.000179	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—PTGS2—amyotrophic lateral sclerosis	9.45e-05	0.000176	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	8.49e-05	0.000158	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.22e-05	0.000153	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.19e-05	0.000152	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.1e-05	0.000151	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.1e-05	0.000151	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.1e-05	0.000151	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.03e-05	0.000149	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.03e-05	0.000149	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.03e-05	0.000149	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.98e-05	0.000149	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.92e-05	0.000147	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.77e-05	0.000145	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.74e-05	0.000144	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	7.56e-05	0.000141	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.98e-05	0.00013	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.95e-05	0.000129	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.23e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.23e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.23e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.15e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.89e-05	0.00011	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.89e-05	0.00011	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.89e-05	0.00011	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.81e-05	0.000108	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.29e-05	9.85e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.29e-05	9.85e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.29e-05	9.85e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.27e-05	9.82e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.25e-05	9.77e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.21e-05	9.71e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.56e-05	8.49e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.19e-05	7.8e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4e-05	7.44e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4e-05	7.44e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4e-05	7.44e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.94e-05	7.33e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	3.45e-05	6.42e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.36e-05	4.4e-05	CbGpPWpGaD
